LGMD – Criss Hartzell, Ph.D.

LGMD - Criss Hartzell, Ph.D.
Criss Hartzell’s work may uncover new disease mechanisms and form the basis for future therapeutic approaches in limb-girdle muscular dystrophy.

Criss Hartzell, professor of cell biology at Emory University School of Medicine in Atlanta, Ga., was awarded an MDA research grant to elucidate the mechanisms underlying type 2L limb-girdle muscular dystrophy (LGMD), caused by mutations in the ANO5 gene. Hartzell will examine the role the ANO5 protein plays in trafficking and fusion of cell membranes during muscle repair, and how mutations in this protein disrupt these functions. The work may uncover unique targets around which to base new therapeutic approaches.

Funding for this MDA research grant began Aug. 1, 2015.